Download ดาวน์โหลด 175 ครั้ง
เข้าชม 467 ครั้ง


Cost-utility analysis of screening for hepatitis B viral infection in Thailand
Narisa Tantai*, Pitsaphun Werayingyong**, Pattara Leelahavarong** and Yot Teerawattananon**
     *Pharmaceutical Department, Faculty of Medicine Siriraj Hospital, Mahidol University, **Health Intervention and
Technology Assessment Program (HITAP), Ministry of Public Health
Hepatitis B virus (HBV) infection is one of the most common health problems in Thailand population,
with its wide-ranging complications affecting the quality of life. The population-base screening of
HBV has not been implemented in Thailand, nor is its cost-effective clear. The study aims to assess the
economic value of alternative HBV screening programs in Thailand, based on societal perspectives and
economic costs. Compared with no screening, both HBsAg and anti-HBs testing combined with HBV
vaccination and HBsAg testing without HBV vaccination were cost-effective in all age groups and all
scenarios of vaccine coverage and could increase the life expectancy while decreasing future costs of
healthcare services. The selection of options should depend on the affordability of each healthcare scheme.